Anxiety Sensitivity Clinical Trial
Official title:
Distance-Based Cognitive-Behavioural Therapy for High Anxiety Sensitivity: A Randomized Controlled Trial
Anxiety disorders are common pervasive conditions with serious psychosocial implications.
Anxiety sensitivity (AS) is one individual characteristic that has been implicated in the
onset and maintenance of anxiety disorders (Schmidt et al., 1999). AS is an enduring fear of
anxiety-related arousal sensations (i.e., increased heart rate) that arises from the
tendency to interpret these sensations catastrophically, believing that they will have
serious physical, psychological, or social consequences (Reiss, 1991).
Research has shown the efficacy of CBT in decreasing AS among women with high AS (Watt et
al., 2006). Unfortunately, access to effective psychological treatments is limited by a
number of barriers such as a lack of treatment availability or qualified clinicians in an
area. As such, we are conducting a randomized controlled trial (RCT) of the effectiveness of
a distance-based CBT program on decreasing AS among those with high AS. A distance delivery
approach (e.g., via telephone) is one way to minimize treatment barriers and increase access
to care while still delivering empirically supported treatment. Recent research suggests
distance delivery is promising (Lovell et al., 2006).
The RCT will consist of an eight-week structured CBT program based on Watt and Stewart's
(2008) brief CBT for AS. The program will include weekly modules on psychoeducation,
cognitive restructuring, interoceptive exposure, and relapse prevention. Participants with
high AS will be recruited and randomly assigned to the treatment condition or wait-list
control (after twelve weeks the wait-list group will receive treatment). In the treatment
condition, participants will be assigned weekly reading and homework from the treatment
manual. In addition, a therapist will guide them through the treatment by providing
individualized support and feedback through weekly half-hour telephone sessions. Treatment
outcomes will be assessed through changes in AS levels and anxiety symptoms pre- to
post-treatment. Also, participants' satisfaction with the mode of treatment delivery will be
assessed. We hypothesize that this treatment program will be effective in reducing high AS
and anxiety symptom frequency and severity. We also expect this project to yield information
about the utility of distance treatment delivery for mental health care.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02874417 -
Computerized Psychoeducation for Anxiety Sensitivity
|
N/A | |
Completed |
NCT03917901 -
Computer-Delivered Intervention for Individuals With Obesity and Elevated Anxiety Sensitivity
|
N/A | |
Recruiting |
NCT05383989 -
The UniVenture Program
|
N/A | |
Active, not recruiting |
NCT05416203 -
BEAST: A Pilot Trial
|
N/A | |
Not yet recruiting |
NCT05490199 -
Brief Enhanced Anxiety Sensitivity Treatment
|
N/A | |
Completed |
NCT03128437 -
Anxiety, Mood, and Health Behaviors in Young Adults
|
N/A | |
Withdrawn |
NCT04259190 -
A Comparison of Treatment Rationales on Willingness to Tolerate Distress in Interoceptive Exposure
|
N/A | |
Enrolling by invitation |
NCT01201304 -
Comparison of Methods for the Delivery of Interoceptive Exposure
|
Phase 2 | |
Completed |
NCT05458362 -
Brief Enhanced Anxiety Sensitivity Treatment (Group)
|
N/A | |
Enrolling by invitation |
NCT04129866 -
Mobile Interpretation Bias Modification Clinical Trial
|
N/A |